Retraction Note to: Cell Death & Disease 9:929
https://doi.org/10.1038/s41419-018-0931-0 published online 11 September 2018
This article was published in error and has been retracted at the request of the authors. During the proofing stage, the authors found that some lanes in Figs. 2b, 2h, 3h and S4a were not the appropriate ones. Shixiu Sun, Yujie Zhang, Jianchao Zheng, Biao Duan, Yan Chen, Wenjie Deng, Bixing Ye, Lei Lui, Yongchang Chen, Jun Du and Luo Gu agree with this retraction. We have been unable to contact Jie Cui. The authors have been given the opportunity to submit a revised manuscript for peer review.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Edited by G. Ciliberto
The original article can be found online at https://doi.org/10.1038/s41419-018-0931-0.
About this article
Cite this article
Sun, S., Zhang, Y., Zheng, J. et al. Retraction Note: HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation. Cell Death Dis 10, 633 (2019). https://doi.org/10.1038/s41419-019-1866-9
Published:
DOI: https://doi.org/10.1038/s41419-019-1866-9
